Recursion Pharmaceuticals, Inc.
RXRXRecursion is a clinical-stage TechBio company that integrates artificial intelligence, machine learning, and automated wet-lab biology to industrialize drug discovery.
Earnings
Next report
Aug 4, 2026 (In 6 days)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
Recursion is a clinical-stage TechBio company that integrates artificial intelligence, machine learning, and automated wet-lab biology to industrialize drug discovery. The company utilizes its proprietary Recursion Operating System (OS) to decode biological patterns and identify novel treatments across various therapeutic areas. By shifting from a traditional high-attrition discovery funnel to an AI-native 'T-shaped' model, the company aims to increase the probability of clinical success while reducing the time and cost of drug development.
A leading TechBio pioneer focused on replacing traditional trial-and-error drug discovery with a scalable, AI-driven automated platform.
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s market cap?
- Recursion Pharmaceuticals, Inc. (RXRX) has a market capitalization of $1.6B and trades on NASDAQ.
- What is Recursion Pharmaceuticals, Inc.'s revenue and profitability?
- Recursion Pharmaceuticals, Inc. generated $66.4M in trailing twelve-month revenue with a net loss of $559.8M, representing a net margin of -842.9%. Gross margin stands at 7.2%, with free cash flow of -$325.8M. These figures are based on the Q1 2026 filing.
- Who are Recursion Pharmaceuticals, Inc.'s competitors?
- Recursion Pharmaceuticals, Inc.'s key competitors include AbCellera, Schrodinger, Relay Therapeutics, and others. These companies compete in similar markets and product categories.
- Who does Recursion Pharmaceuticals, Inc. partner with?
- Recursion Pharmaceuticals, Inc.'s notable partners include NVIDIA, Roche, Bayer.
- What subsidiaries does Recursion Pharmaceuticals, Inc. have?
- Recursion Pharmaceuticals, Inc.'s subsidiaries include Valence Labs.
- Where is Recursion Pharmaceuticals, Inc. headquartered?
- Recursion Pharmaceuticals, Inc. is headquartered in United States of America and employs approximately 500 people. It has been publicly traded since 2021.
